Expanding Adenoviral Vectors to Novel Therapeutic Applications

This inventive concept leverages the core technology of adenoviral vectors derived from chimpanzee adenovirus to address unmet needs in cancer treatment, gene therapy, neurodegenerative diseases, livestock health, and regenerative medicine.

The original patent disclosed adenoviral vectors for vaccine applications, but these vectors have untapped potential in other therapeutic areas. The new inventive concept addresses the limitations of traditional treatment approaches in these fields by harnessing the unique properties of chimpanzee adenovirus-derived vectors.

The new inventive concept involves engineering adenoviral vectors derived from chimpanzee adenovirus to selectively target and destroy cancer cells, cross the blood-brain barrier for gene therapy, express neuroprotective proteins for neurodegenerative diseases, express antigens for livestock health, and promote tissue regeneration and repair. These vectors can be tailored to specific disease indications and administered via various routes to achieve optimal therapeutic outcomes.

The new inventive concept's novelty lies in its application of chimpanzee adenovirus-derived vectors to novel therapeutic areas, which was not contemplated in the original patent. The inventive step resides in the innovative engineering of these vectors to address specific disease needs and overcome existing treatment limitations.

Alternative embodiments may include using different serotypes of chimpanzee adenovirus, incorporating additional genetic elements, or combining these vectors with other therapeutic modalities. Variations may involve targeting different disease indications or developing novel vector delivery systems.

The new inventive concept has significant commercial potential in various industries, including oncology, neurology, veterinary medicine, and regenerative medicine. The target market includes pharmaceutical and biotechnology companies, research institutions, and hospitals seeking innovative solutions for unmet medical needs.